DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Storey RF, Gurbel PA, Ten Berg J. et al.
Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes.
Eur Heart J 2020;
41 (33) 3132-3140
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.